| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 8.252 | 23.260 | 32.457 | 45.978 |
| Total Income - EUR | - | - | - | - | - | - | 8.252 | 23.260 | 32.457 | 59.205 |
| Total Expenses - EUR | - | - | - | - | - | - | 6.826 | 15.236 | 25.729 | 54.464 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 1.426 | 8.023 | 6.728 | 4.741 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 1.178 | 7.325 | 5.652 | 3.362 |
| Employees | - | - | - | - | - | - | 0 | 0 | 3 | 3 |
Check the financial reports for the company - Kinemedicine S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 2.893 | 7.634 | 43.506 | 24.674 |
| Current Assets | - | - | - | - | - | - | 43 | 1.768 | 2.980 | 2.475 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 938 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Cash | - | - | - | - | - | - | 43 | 1.768 | 2.042 | 2.475 |
| Shareholders Funds | - | - | - | - | - | - | 1.219 | 8.547 | 4.155 | 12.506 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 1.718 | 855 | 42.331 | 14.643 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Kinemedicine S.r.l.